US Patent Issued to Interlude Biopharma, Oklahoma Medical Research Foundation on Sept. 16 for "Compositions and methods for treating Sjogren's syndrome" (North Carolina, Oklahoma Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,979, issued on Sept. 16, was assigned to Interlude Biopharma Co. (Miami) and Oklahoma Medical Research Foundation (Oklahoma City).

"Compositions and methods for treating Sjogren's syndrome" was invented by Jay P. Madan (Raleigh, N.C.), Kathy L. Sivils (Oklahoma City), Umesh Deshmukh (Oklahoma City), Balasingham Radhakrishnan (Raleigh, N.C.), Kendyle Kennsengten (Raleigh, N.C.) and Harini Bagavant (Oklahoma City).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods for treating Sjogren's syndrome (SS), including primary or secondary SS, as well as methods for preventing clinical disease in patients at...